Press Releases

Washington – Senator Dianne Feinstein (D-Calif.) joined Senator Amy Klobuchar (D-Minn.) and 15 of their colleagues on a letter urging the Federal Trade Commission (FTC) to protect consumers from price gouging. The senators call on the agency to use the full extent of its authority to prevent abusive price gouging on consumer health products that help prevent the spread of coronavirus.

“The FTC, as our nation’s top consumer protection enforcer, must do everything in its power to address price gouging for consumer health products during this national emergency,” the senators wrote. “Although there is no federal law outlawing price gouging, as a general matter, the Federal Trade Commission Act (FTC Act) grants the FTC the power to prevent “unfair or deceptive acts or practices.” Charging outrageously inflated prices for everyday consumer health products in the middle of a global pandemic certainly fits that description. And make no mistake, the price gouging we are seeing has nothing to do with “supply-and-demand” or “price discovery”—it has everything to do with squeezing every last cent out of consumers in a time of desperate need.”

In addition to Feinstein and Klobuchar, the letter was signed by Senators Doug Jones (D-Ala.), Sherrod Brown (D-Ohio), Chris Van Hollen (D-Md.), Richard Blumenthal (D-Conn.), Mazie Hirono (D-Hawaii), Catherine Cortez Masto (D-Nev.), Ben Cardin (D-Md.), Cory Booker (D-N.J.), Kamala Harris (D-Calif.), Tina Smith (D-Minn.), Tammy Duckworth (D-Ill.), Bernie Sanders (I-Vt.), Elizabeth Warren (D-Mass.), Jacky Rosen (D-Nev.) and Tom Udall (D-N.M.).

The full text of the letter can be found here and below:

Dear Chairman Simons:

We call on the Federal Trade Commission (FTC) to use the full extent of its authority to prevent abusive price gouging on consumer health products that members of the public need to protect themselves and their loved ones from the spread of the coronavirus (COVID-19).  

We are in the midst of a global health care crisis. The latest reports indicate that more than 85,000 people across our country have tested positive for coronavirus – a number that is likely far short of the actual total in light of deeply troubling limitations on testing – and at least 1,271 patients with the virus have died. And in the near term, these numbers are only expected to rise.

Serious and justified public concern about the growing pandemic has drastically increased demand for consumer health products that can help stem the spread of COVID-19. Everyday products, like hand sanitizer, facemasks, soap, and even household disinfectants such as Lysol and Clorox, have been emptied from store and warehouse shelves by consumers trying to protect themselves and their families from the virus. Many consumers have turned to e-commerce sites only to find similar shortages.   

But just as times of crisis can bring out the best in people, they can also bring out the worst. And that is what we have been seeing in numerous reports of unscrupulous vendors taking advantage of this national emergency by charging wildly inflated prices for once-affordable consumer products. Such price gouging does not just enrich sellers at the expense of desperate consumers, it may prevent low income consumers from obtaining these products altogether. Some e-commerce businesses have undertaken efforts to prevent price gouging by third-party vendors on their websites, but such efforts are insufficient to address the broader problem. Several states have enacted measures to address price gouging, and some of them have already taken action. But this is a national problem that requires a solution that protects all Americans, not just those lucky enough to live in a state with protections against price gouging.

The FTC, as our nation’s top consumer protection enforcer, must do everything in its power to address price gouging for consumer health products during this national emergency. Although there is no federal law outlawing price gouging, as a general matter, the Federal Trade Commission Act (FTC Act) grants the FTC the power to prevent “unfair or deceptive acts or practices.” Charging outrageously inflated prices for everyday consumer health products in the middle of a global pandemic certainly fits that description. And make no mistake, the price gouging we are seeing has nothing to do with “supply-and-demand” or “price discovery” – it has everything to do with squeezing every last cent out of consumers in a time of desperate need.    

Under normal circumstances, the FTC has been reticent to employ the full extent of its authority under Section 5 of the FTC Act. But these are not normal circumstances. If ever there was a time to explore the limits of the FTC’s consumer protection authority, that time has come. The FTC must take urgent action to address these abuses. We stand ready to assist the Commission in its efforts, and if the agency would benefit from additional authority to address this harmful conduct, we would be happy to consult with you and your fellow Commissioners on appropriate legislation.  

Thank you for your immediate attention to this matter.

Sincerely,

Amy Klobuchar

United States Senator

Doug Jones

United States Senator

Sherrod Brown

United States Senator

Chris Van Hollen

United States Senator

Richard Blumenthal

United States Senator

Mazie Hirono

United States Senator

Catherine Cortez Masto

United States Senator

Benjamin L. Cardin

United States Senator

Dianne Feinstein

United States Senator

Cory A. Booker

United States Senator

Kamala D. Harris

United States Senator

Tina Smith

United States Senator

Tammy Duckworth

United States Senator

Bernard Sanders

United States Senator

Elizabeth Warren

United States Senator

Jacky Rosen

United States Senator

Tom Udall

United States Senator

###